| abstract |
The present invention provides compounds of formula (l) and pharmaceutically acceptable salts thereof, (see formula I) wherein L, X, R a, R b, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment or prevention of conditions having an association with the orexin sub-type 1 receptor. |